Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max F Levine

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Pathology, Research and Practice|April 21, 2026
Whole genome sequencing of locally advanced and metastatic breast carcinoma unravels relevant molecular signatures and novel eventsEda Nur Kozan, Jesús Delgado-de la Mora, Majd Al Assaad, et al.
Blood Advances|March 3, 2023
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemiaDaniel Leongamornlert, Jesús Gutiérrez-Abril, SooWah Lee, et al.
Molecular Cancer Research : MCR|March 23, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell TumorEmily K Slotkin, Anita S Bowman, Max F Levine, et al.
Nature Communications|August 8, 2022
Unified classification and risk-stratification in Acute Myeloid LeukemiaYanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Nature Genetics|May 11, 2023
Clonal evolution during metastatic spread in high-risk neuroblastomaGunes Gundem, Max F Levine, Stephen S Roberts, et al.
Cancer Discovery|March 17, 2019
Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel <i>AKT1</i> Fusion-Driven CancerEmily K Slotkin, Daniel Diolaiti, Neerav N Shukla, et al.
Communications Medicine|January 12, 2026
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohortMajd Al Assaad, Kevin Hadi, Max F Levine, et al.
Nature Genetics|August 6, 2025
Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastomaGunes Gundem, Max F Levine, Stephen S Roberts, et al.
Blood Advances|October 26, 2020
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phaseJohn O Mascarenhas, Raajit K Rampal, Heidi E Kosiorek, et al.
The American Journal of Surgical Pathology|December 4, 2023
NIPBL::NACC1 Fusion Hepatic CarcinomaErika Hissong, Majd Al Assaad, Munita Bal, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Pathology, Research and Practice|April 21, 2026
Whole genome sequencing of locally advanced and metastatic breast carcinoma unravels relevant molecular signatures and novel eventsEda Nur Kozan, Jesús Delgado-de la Mora, Majd Al Assaad, et al.
Blood Advances|March 3, 2023
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemiaDaniel Leongamornlert, Jesús Gutiérrez-Abril, SooWah Lee, et al.
Molecular Cancer Research : MCR|March 23, 2021
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell TumorEmily K Slotkin, Anita S Bowman, Max F Levine, et al.
Nature Communications|August 8, 2022
Unified classification and risk-stratification in Acute Myeloid LeukemiaYanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Nature Genetics|May 11, 2023
Clonal evolution during metastatic spread in high-risk neuroblastomaGunes Gundem, Max F Levine, Stephen S Roberts, et al.
Cancer Discovery|March 17, 2019
Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel <i>AKT1</i> Fusion-Driven CancerEmily K Slotkin, Daniel Diolaiti, Neerav N Shukla, et al.
Communications Medicine|January 12, 2026
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohortMajd Al Assaad, Kevin Hadi, Max F Levine, et al.
Nature Genetics|August 6, 2025
Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastomaGunes Gundem, Max F Levine, Stephen S Roberts, et al.
Blood Advances|October 26, 2020
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phaseJohn O Mascarenhas, Raajit K Rampal, Heidi E Kosiorek, et al.
The American Journal of Surgical Pathology|December 4, 2023
NIPBL::NACC1 Fusion Hepatic CarcinomaErika Hissong, Majd Al Assaad, Munita Bal, et al.
Pageof 3